How should a normal breast examination be described in the review of systems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Breast Examination Documentation in Review of Systems

A normal breast examination in the review of systems should be documented as: "No breast masses, lumps, skin changes, nipple discharge, or palpable lymph nodes; breasts symmetric with no erythema, retraction, dimpling, or nipple abnormalities." 1

Key Components to Document for Normal Findings

Visual Inspection Elements

When documenting a normal breast exam, you should specifically note:

  • Symmetry: Breasts are symmetric in shape and contour with no visible asymmetries 1
  • Skin appearance: No erythema, retraction, or dimpling present 1
  • Nipple status: No nipple changes, scaling, or inversion 1

Palpation Elements

For a normal palpation finding, document:

  • No discrete masses: Absence of palpable masses or focal asymmetries 1
  • No spontaneous nipple discharge: This is critical—only spontaneous discharge warrants concern, not discharge from squeezing 1
  • Lymph nodes: No palpable axillary, supraclavicular, or infraclavicular lymph nodes 1

Standardized Reporting Framework

The guideline explicitly states that reporting should consist of "a summary of relevant portions of a patient's history and a description of whether the CBE is interpreted as normal/negative or abnormal" 1.

For a normal/negative interpretation, this means: "No abnormalities on visual inspection or palpation." 1

Important Clinical Nuances

Nodularity vs. Masses

A critical pitfall is distinguishing physiologic nodularity from discrete masses 2, 3. Normal breasts can have:

  • Generalized nodularity that varies with menstrual cycle
  • Tissue that feels firmer in the upper outer quadrant
  • Symmetric texture bilaterally

These are normal findings and should be documented as such, not as "abnormal" 3. The key is whether findings are symmetric and consistent with the patient's typical breast anatomy 3.

What NOT to Include

Do not document normal physiologic variations as abnormalities:

  • Cyclic breast tenderness
  • Generalized symmetric nodularity
  • Normal tissue density variations

Risk Context Matters

While documenting the normal exam, the clinical history portion should capture relevant risk factors that provide context: age, personal/family history of breast disease, hormonal therapy use, and prior breast procedures 1. However, these belong in the history section, not the physical exam documentation.

Practical Documentation Template

For ROS documentation of normal breast exam: "Denies breast lumps, masses, skin changes, nipple discharge, or breast pain. Clinical breast examination: breasts symmetric, no skin erythema/retraction/dimpling, nipples normal without discharge, no palpable masses or lymphadenopathy. Interpretation: Normal/Negative."

This approach provides a baseline for future comparison 1 and meets the standardized reporting framework recommended by expert consensus 1.

References

Research

Clinical breast examination.

The Western journal of medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.